Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers
NCT01779024 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2018-08-03
Summary
Background:
\- Ghrelin is a hormone in the human body that is mostly produced by the stomach. It makes people feel hungry, and also is connected with the desire to drink alcohol. Researchers want to test ghrelin to see if it can be used to control alcohol cravings and use. They will compare doses of ghrelin with a placebo in people who drink heavily.
Objectives:
\- To study the effects of ghrelin on alcohol craving and use.
Eligibility:
* Individuals between 21 and 60 years of age who are heavy drinkers but are not seeking treatment for alcohol use.
* Participants must on average have more than 20 drinks per week for men, and more than 15 drinks per week for women.
Design:
* Participants will have a screening visit, four 2-night study visits, and a follow-up visit.
* Participants will be screened with a physical exam and medical history. They will provide urine and breath samples for drug testing. They will also answer questions about mood and physical symptoms, and about alcohol and other cravings.
* At the study visits, participants will stay overnight at the National Institutes of Health clinical center. They will spend the night at the center, have tests on the next day, and go home on the following morning. At each visit, participants will receive a ghrelin or placebo infusion, and will complete a series of tasks.
* For the first and second study visits, participants will have tests of alcohol craving and use. They will be able to receive alcohol infusions through a computer program that tests response time and craving reactions. At the same time, they will have a ghrelin or a placebo infusion. Blood alcohol levels, reaction time, and craving will be studied.
* For the third and fourth study visits, participants will have a magnetic resonance imaging (MRI) study. They will have an initial MRI to provide a picture of the brain. They will then have a functional MRI during which they will respond to a computer test. The test will allow them to win points for snack food or alcohol. This test will look at the brain s response time and craving reactions.
* There will be a follow-up visit 1 week after the fourth study visit. Some of the tests from the screening visit will be repeated.
Conditions
- fMRI
- Alcohol Drinking
- Alcoholism
Interventions
- DRUG
-
Ghrelin
- DRUG
- PROCEDURE
-
fMRI
- DRUG
-
Alcohol
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
lead NIH
Principal Investigators
-
Lorenzo Leggio, M.D. · National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-12-13
- Primary Completion
- 2017-06-01
- Completion
- 2017-06-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant
NCT05203965 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
CRF1 Antagonist GSK561679 in Alcoholism
NCT01187511 ·Status: COMPLETED ·Phase: PHASE2
-
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
NCT02989662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers
NCT06885190 ·Status: NOT_YET_RECRUITING
-
Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
NCT04896489 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hangover, Congeners, Sleep and Occupational Performance
NCT00247585 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence
NCT02196142 ·Status: COMPLETED ·Phase: PHASE3
-
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
NCT01227980 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part II
NCT02707055 ·Status: TERMINATED ·Phase: PHASE2
-
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
NCT04971681 ·Status: TERMINATED ·Phase: NA
-
The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
NCT00667771 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glutamatergic Modulation of Disordered Alcohol Use
NCT02539511 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
NCT04084860 ·Status: RECRUITING ·Phase: PHASE2
-
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
NCT00612352 ·Status: COMPLETED ·Phase: NA
-
The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders
NCT03872128 ·Status: COMPLETED ·Phase: PHASE1
-
Neural Mechanisms Underlying Alcohol Induced Disinhibition
NCT01097213 ·Status: COMPLETED
-
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
NCT06136195 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of GSK598809 on Brain Activation in Abstinent Alcoholics
NCT00908206 ·Status: WITHDRAWN ·Phase: PHASE1
-
Alcohol and Neural Cardiovascular Control in Binge Drinkers
NCT03567434 ·Status: COMPLETED ·Phase: NA
-
Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder
NCT06866379 ·Status: RECRUITING ·Phase: NA
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NCT03535129 ·Status: COMPLETED ·Phase: NA
-
Neural Substrates of Approach-Avoidance Conflict
NCT02119624 ·Status: COMPLETED
-
Alcohol and Cigarette Craving During Oxytocin Treatment
NCT04071119 ·Status: COMPLETED ·Phase: PHASE1
-
Neural Correlates During Alcohol Intoxication
NCT06118580 ·Status: RECRUITING ·Phase: PHASE2